Mika Okamoto

Kagoshima, 8908580, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Structure-activity relationship of neplanocin A analogues for the identification of novel anti-HBV leads.

Structure-activity relationship of neplanocin A analogues for the identification of novel anti-HBV leads.

Journal: Organic & biomolecular chemistry

Published: March 25, 2026

Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs.

Design, Synthesis, and Anti-SARS-CoV-2 Activity of Amodiaquine Analogs.

Journal: Chemical & pharmaceutical bulletin

Published: April 16, 2025

In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations.

In Silico Discovery of SARS-CoV-2 Main Protease Inhibitors Using Docking, Molecular Dynamics, and Fragment Molecular Orbital Calculations.

Journal: The journal of physical chemistry. B

Published: January 31, 2025

Potential of fat-soluble vitamins as a platform for antiviral drug development.

Potential of fat-soluble vitamins as a platform for antiviral drug development.

Journal: Bioorganic & medicinal chemistry letters

Published: January 03, 2025

Pyrazolo[3,4-d]pyrimidine-based neplanocin analogues identified as potential de novo pharmacophores for dual-target HBV inhibition.

Pyrazolo[3,4-d]pyrimidine-based neplanocin analogues identified as potential de novo pharmacophores for dual-target HBV inhibition.

Journal: RSC medicinal chemistry

Published: November 28, 2024

Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro.

Sulfoquinovosyl diacylglycerol, a component of Holy Basil Ocimum tenuiflorum, inhibits the activity of the SARS-CoV-2 main protease and viral replication in vitro.

Journal: Journal of natural medicines

Published: September 19, 2024

Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication.

Amodiaquine derivatives as inhibitors of severe fever with thrombocytopenia syndrome virus (SFTSV) replication.

Journal: Antiviral research

Published: October 23, 2022

Novel RT-PCR Using Sugar Chain-Immobilized Gold-Nanoparticles Correlates Patients' Symptoms: The Follow-Up Study of COVID-19 Hospitalized Patients.

Novel RT-PCR Using Sugar Chain-Immobilized Gold-Nanoparticles Correlates Patients' Symptoms: The Follow-Up Study of COVID-19 Hospitalized Patients.

Journal: Viruses

Published: September 23, 2022

Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action.

Novel Neplanocin A Derivatives as Selective Inhibitors of Hepatitis B Virus with a Unique Mechanism of Action.

Journal: Antimicrobial agents and chemotherapy

Published: May 23, 2022

Induction of E. coli-derived endonuclease MazF suppresses HIV-1 production and causes apoptosis in latently infected cells.

Induction of E. coli-derived endonuclease MazF suppresses HIV-1 production and causes apoptosis in latently infected cells.

Journal: Biochemical and biophysical research communications

Published: July 11, 2020

The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.

The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro.

Journal: Antiviral research

Published: June 18, 2020

Novel Anti-CD70 Antibody Drug Conjugate for the Treatment of Adult T-Cell Leukemia (ATL).

Novel Anti-CD70 Antibody Drug Conjugate for the Treatment of Adult T-Cell Leukemia (ATL).

Journal: Anticancer research

Published: April 18, 2020

Showing 1-12 of 26

Last Updated: 09/26/2026